Not Accessible: Data From Pivotal Trials of New Cancer Drugs
Individual patient data is available for less than half of the clinical trials that underpin the FDA approval of new cancer drugs, a new analysis reveals.
Medscape Medical News
source https://www.medscape.com/viewarticle/978603?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/978603?src=rss
Comments
Post a Comment